phosphodiesterase 4 inhibitors

Preferred Label : phosphodiesterase 4 inhibitors;

MeSH definition : Compounds that specifically inhibit PHOSPHODIESTERASE 4.;

MeSH synonym : inhibitors, phosphodiesterase 4; phosphodiesterase type 4 inhibitors; PDE-4 inhibitors; inhibitors, PDE-4; PDE 4 inhibitors; PDE4 inhibitors; inhibitors, PDE4; PDE-4 Inhibitor; Inhibitor, PDE-4; PDE 4 Inhibitor; Phosphodiesterase Type 4 Inhibitor; Phosphodiesterase 4 Inhibitor; 4 Inhibitor, Phosphodiesterase; Inhibitor, Phosphodiesterase 4; PDE4 Inhibitor; Inhibitor, PDE4;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D058988;

UMLS CUI

C2936609;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Substance with phosphodiesterase 4 inhibitor mechanism of action (substance) [SNOMED CT concept]
Indexing information
- (-)-7-(3-(cyclopentyloxy)-4-methoxyphenyl)hexahydro-3H-pyrrolizin-3-one [MeSH Supplementary Concept]
- 1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester [MeSH Supplementary Concept]
- 3-(1-(3-cyclopropylmethoxy-4-difluoromethoxybenzyl)-1H-pyrazol-3-yl)benzoic acid [MeSH Supplementary Concept]
- 5-chloro-6-(1-hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-5-yloxy)-2-(2-isopropoxyethoxy)nicotinonitrile [MeSH Supplementary Concept]
- bhimamycin H [MeSH Supplementary Concept]
- bhimamycin I [MeSH Supplementary Concept]
- bresol [MeSH Supplementary Concept]
- langkolide [MeSH Supplementary Concept]
- methyl 4-(((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)amino)carbonyl)benzoate [MeSH Supplementary Concept]
- roflumilast [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- cyclic nucleotide phosphodiesterases, type 4 [MeSH Descriptor]
Record concept(s)
- phosphodiesterase 4 inhibitors [MeSH concept]
See also (suggested by CISMeF)
- apremilast [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Phosphodiesterase 4 inhibitor (disposition) [SNOMED CT concept]
- Product containing phosphodiesterase 4 inhibitor (product) [SNOMED CT concept]
- Tranimilast [NCIt concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(4-(difluoromethoxy)-3-((tetrahydrofuran-3-yl)oxy)phenyl)-3-methylbutan-1-one [MeSH Supplementary Concept]
- 4-cyano-4-(2,3-dihydro-8-methoxy-1,4-benzodioxin-5-yl)cyclohexanecarboxylic acid [MeSH Supplementary Concept]
- 6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide [MeSH Supplementary Concept]
- BPN14770 [MeSH Supplementary Concept]
- CC-11050 [MeSH Supplementary Concept]
- CI 1044 [MeSH Supplementary Concept]
- Cilomilast [MeSH Supplementary Concept]
- Hemay005 [MeSH Supplementary Concept]
- KW 4490 [MeSH Supplementary Concept]
- MK 0873 [MeSH Supplementary Concept]
- Zl-n-91 compound [MeSH Supplementary Concept]
- apremilast [MeSH Supplementary Concept]
- piclamilast [MeSH Supplementary Concept]
- roflumilast N-oxide [MeSH Supplementary Concept]
- roflupram [MeSH Supplementary Concept]
- rolipram [MeSH Descriptor]
UMLS correspondences (same concept)
- Product containing phosphodiesterase 4 inhibitor (product) [SNOMED CT concept]
- Substance with phosphodiesterase 4 inhibitor mechanism of action (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients